|
|
Marshall Edwards, Inc.'s Action Intended to Regain Compliance With Nasdaq Share Price Rule, Benefit Shareholde
|
Marshall Edwards, Inc.'s Action Intended to Regain Compliance With Nasdaq Share Price Rule, Benefit Shareholde
|
Marshall Edwards, Inc.'s Action Intended to Regain Compliance With Nasdaq Share Price Rule, Benefit Shareholders
|
(CVS) SqueezeTrigger Price is $32.942. There is $616,280,045.00 That Short Sellers Still Need To Cover
|
Aastrom Biosciences Inc. Reports Operating Results (10-Q)
|
Array BioPharma Inc. (ARRY) CFO Michael Carruthers sells 6,286 Shares
|
Novo Nordisk A/S - Transaction in Own Shares
|
Novo Nordisk A/S - Transaction in Own Shares
|
FDA Advisory Panel To Review Cell Therapeutics' Pixantrone
|
Latin American Minerals Inc. Applies for Extension of Warrants Exercisable for Common Shares at $0.50 Per Comm
|
Orbus Pharma Inc. Announces Progress on its Private Placement with Nanjing Sanhome Pharmaceutical Co., Ltd
|
Regeneron Pharmaceuticals Inc. (REGN) SVP F&A, CFO, Treas & Asst Sec Murray A Goldberg sells 6,105 Shares
|
The Futura Loyalty Group Completes First Tranche of Private Placement Financing
|
Orbus Pharma Inc. Announces Progress on its Private Placement with Nanjing Sanhome Pharmaceutical Co., Ltd.
|
US Airways Waves Change Fees
|
Rye Patch Gold Corp. Issues Shares and Warrants to Finder in Substitution for Compensation Option
|
Just Energy Exchange Corp. Announces February Dividend
|
Human Genome Sciences Inc. (HGSI) CFO Timothy C Barabe sells 22,907 Shares
|
Douglas Halward Announces Acquisition of Shares of Consolidated Envirowaste Industries Inc
|
Banco Santander, GlaxoSmithKline Net Rises
|
